People paying cash for their prescription may also access Wegovy injection on Ro (if prescribed) for $199 per month for the first two months, then $349 per month thereafter
Third, when retatrutide becomes available and you start seeing claims about it, the question to ask your doctor is not "does it work?" but "for my specific situation, what does it improve that we already know about, and what hasn't been studied yet?" Weight, blood-sugar control, and liver fat sit on strong evidence
Another key compound available is Semaglutide , a GLP-1 receptor agonist widely examined in metabolic and biochemical research settings
However, significant risks and limitations must be considered
Unlike earlier GLP-1 receptor agonists, retatrutide is a triple agonist : GLP-1 receptor agonist suppresses appetite, slows gastric emptying, improves insulin sensitivity GIP receptor agonist enhances insulin release, amplifies GLP-1 effects Glucagon receptor agonist stimulates energy expenditure, fat metabolism, and potentially impacts lipid handling Clinical trials so far have shown remarkable weight loss (up to 24% in some studies) and strong metabolic improvements, including effects on lipids like LDL cholesterol